# Companies at Oncology & Immunology Innovation Partnering & Licensing Summit

13 organisations named on published listings for Oncology & Immunology Innovation Partnering & Licensing Summit: 13 companies on stage.
From the listings Oncology & Immunology Innovation Partnering & Licensing Summit prints on its own site. No registration data, and no individual attendees. Being listed is not an endorsement.
Last checked 2026-09-11. 9 September 2026 to 10 September 2026, Boston, MA, Boston, United States.

This event has ended.

## Companies on stage (13)

- Daiichi Sankyo
- Ipsen Pharma
- Astellas Pharma
- Merck & Co
- Inc
- Boehringer Ingelheim
- Johnson & Johnson
- UCB
- Deep Track Capital
- Eli Lilly & Co
- Takeda Pharmaceutical
- VU Venture Partners
- AstraZeneca

Oncology & Immunology Innovation Partnering & Licensing Summit is a trademark of its organiser. This page is an independent summary of listings published for the event. Being listed here is not an endorsement of the event, of Luminik, or of anything else. Luminik is not affiliated with the event.

Source page: https://www.luminik.io/events/oncology-immunology-innovation-partnering-licensing-summit-boston/companies/
Event page: https://www.luminik.io/events/oncology-immunology-innovation-partnering-licensing-summit-boston/